Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
207 Leser
Artikel bewerten:
(1)

Black Book Research: XiFin, Inc. Achieves Seventh Consecutive #1 Client Experience Rating in Laboratory and Ancillary Revenue Cycle Services, Black Book 2025 Survey

SAN DIEGO, CA / ACCESS Newswire / November 19, 2025 / Black Book Market Research LLC has announced the 2025 rankings for outsourced revenue cycle management (RCM) solutions in laboratory and ancillary healthcare sectors, confirming XiFin, Inc. as the #1-rated provider in client experience for the seventh consecutive year.

The 2025 Ancillary RCM User Survey gathered responses from 3,275 verified participants across 2,566 provider organizations, representing hospital outpatient departments, reference and diagnostic laboratories, pathology practices, imaging and radiology centers, and ancillary clinics. Respondents included CFOs, RCM directors, HIM specialists, and clinical operations leaders from across the United States.

XiFin Extends Market Leadership

XiFin earned top scores across 10 of 18 key performance indicators, maintaining its dominance over 19 national competitors in the ancillary RCM services category. In 2025, XiFin's composite mean score of 9.61/10 positioned it once again as the highest-rated vendor across all functional user groups: executive, operational, technical, and frontline clinical staff

XiFin ranked #1 in Strategic Alignment of Client Goals: ONC, MACRA, MIPS, VBC, Growth Initiatives, Outcome Initiatives; Innovation and Adaptability; Client relationships and cultural fit; Trust, Transparency, Accountability, Ethics' Breadth of offerings, client types, delivery excellence; Integration and interfaces; Scalability, client adaptability, flexible pricing; Data security, compliance privacy and risk proactivity; Support and customer care quality; and Denial Prevention, Best of breed technology and process improvement. This performance underscores XiFin's reputation for combining advanced automation, interoperability, and client-centric service delivery across laboratories, imaging, and diagnostic networks

"XiFin continues to exceed ancillary client expectations year after year," said Doug Brown, President of Black Book Research. "The company's unmatched consistency across financial leadership, operational execution, and client relationship categories once again makes it the benchmark for RCM excellence in laboratory and radiology sectors."

Survey Trends: Managed Ancillary RCM Momentum Accelerates

The 2025 survey revealed that 81% of outpatient laboratories and diagnostic imaging facilities are actively transitioning to outsourced RCM models to counter mounting pressures from prior authorization expansion, payer documentation creep, and site-neutral reimbursement.

Respondents cited cash collections optimization, denial prevention, and AI-driven first-pass yield improvements as key motivations for outsourcing.
Black Book's findings highlight that laboratories and imaging centers that leverage integrated RCM and clinical systems - LIS/RIS/EMR synchronization - achieve 15% higher first-pass yield and 28% faster A/R turnaround than organizations using siloed billing platforms.

Industry Insights: The 2026 Outlook

Black Book's analysis underscores that ancillary RCM is now a frontline strategic function, not a back-office task. Radiology and laboratory providers face converging challenges:

  • Z-code and AUC mandates expanding into commercial payer environments

  • AI-assisted denial prevention becoming the top differentiator for RCM vendors

  • Site-neutral reimbursement continuing to erode hospital outpatient margins

  • Patient-pay transparency becoming mandatory under the No Surprises Act

The report projects continued consolidation among multi-modality RCM vendors and the mainstream adoption of predictive denial-prevention engines by 2026. Download to see the top performing Ancillary RCM vendors at https://blackbookmarketresearch.com/review-free-reports

About Black Book

Black Book Market Research LLC provides unbiased data and rankings to healthcare IT buyers, media, and investors, delivering independent vendor performance evaluations across technology and outsourced services. With over 3.5 million validated survey viewpoints gathered since 2011, Black Book remains the healthcare industry's largest and most respected customer experience poll. Laboratory stakeholders can download gratis State of the Laboratory Information Systems insight reports also at https://blackbookmarketresearch.com/the-2026-black-book-report-of-the-state-of-healthcare-laboratory-it-solutions Follow @blackbookpolls on Twitter and Black Book Market Research LLC on LinkedIn for the latest findings.

Contact Information

Press Office
research@blackbookmarketresearch.com
8008637590

.

SOURCE: Black Book Research



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/xifin-inc.-achieves-seventh-consecutive-%231-client-experience-rating-i-1093093

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.